Results 1-125 of 125 (Search time: 0.001 seconds).
| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link | |
|---|---|---|---|---|---|---|---|
| 1 | 2008 | A three-point method for estimating wave reflection of obliquely incident waves over a sloping bottom | Wang, S. K.; Tai-Wen Hsu ; Ou, S. H.; Wen-Kai Weng | Coastal Engineering | |||
| 2 | 2011 | Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation | Laport, G. G.; Sheehan, K.; Baker, J.; Armstrong, R.; Wong, R. M.; Lowsky, R.; Johnston, L. J.; Shizuru, J. A.; Miklos, D.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S. | Biology of Blood and Marrow Transplantation | |||
| 3 | 2015 | Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile | Percival, M. E. M.; Medeiros, B. C.; Tian, L.; Robeson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Bone Marrow Transplantation | |||
| 4 | 2015 | Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning | Rezvani, A. R.; Kanate, A. S.; Efron, B.; Chhabra, S.; Kohrt, H. E.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Benjamin, J. E.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Strober, S.; Lowsky, R. | Bone Marrow Transplantation | |||
| 5 | 2020 | Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Significant Increase in Survival in the Post-Targeted Immunotherapy Era | Muffly, L.; Arai, S.; Johnston, L.; Lowsky, R.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A.; Shiraz, P.; Shizuru, J. A.; Sidana, S.; Wen-Kai Weng ; Cunanan, K. | Biology of Blood and Marrow Transplantation | |||
| 6 | 2016 | Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors | Spinner, M. A.; Vina, M. F.; Elder, L.; Arai, S.; Johnston, L.; Meyer, E.; Miklos, D.; Muffly, L.; Negrin, R. S.; Shizuru, J.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R. | Blood | |||
| 7 | 2013 | AN EXPERIMENTAL STUDY OF REGULAR LONG CRESTED WAVES OVER A CRESCENT TYPE SHOAL | Jaw-Guei Lin ; Hsiao, C. S.; Wen-Kai Weng | Journal of Marine Science and Technology-Taiwan | |||
| 8 | 2002 | Analysis of IgG Fc receptor Fc gamma RIIIa polymorphism in relapsed follicular non-Hodgkin's lymphoma patients treated with Rituximab | Wen-Kai Weng ; Levy, R. | Blood | |||
| 9 | 2007 | Analysis of responses of floating dual pontoon structure | Wen-Kai Weng ; Chou, C. R. | China Ocean Engineering | |||
| 10 | 2015 | Analysis of the Dynamics of a Floating body with Thin Skirts by Using the Dual Boundary Element Method | Wen-Kai Weng ; Ruey-Syan Shih ; Duc-Tru Tran | Journal of Marine Science and Technology | 0 | ||
| 11 | 2003 | Analysis of tumor-specific T cell immune response in follicular non-Hodgkin's lymphoma patients treated with rituximab | Wen-Kai Weng ; Levy, R. | Blood | |||
| 12 | 2021 | Analysis of vortex formation and energy dissipation during interaction of solitary-like waves with submerged breakwaters based on particle image velocimetry | Li, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai ; Liao, Ting-Wei | APPLIED OCEAN RESEARCH | 5 | ||
| 13 | 2008 | The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells | Luqman, M.; Klabunde, S.; Lin, K.; Georgakis, G. V.; Cherukuri, A.; Holash, J.; Goldbeck, C.; Xu, X. M.; Kadel, E. E.; Lee, S. H.; Aukerman, S. L.; Jallal, B.; Aziz, N.; Wen-Kai Weng ; Wierda, W.; O'Brien, S.; Younes, A. | Blood | |||
| 14 | 2007 | Autologous cytokine-induced killer cells as post-transplant cellular immunotherapy | Arai, S.; Sheehan, K.; Moore, S.; Laport, G.; Johnston, L.; Lowsky, R.; Miklos, D.; Goldstein, K.; Wen-Kai Weng ; Shizuru, J.; Horning, S.; Negrin, R. | Blood | |||
| 15 | 2020 | Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial | Frank, M. J.; Khodadoust, M. S.; Czerwinski, D. K.; Haabeth, O. A. W.; Chu, M. P.; Miklos, D. B.; Advani, R. H.; Alizadeh, A. A.; Gupta, N. K.; Maeda, L. S.; Reddy, S. A.; Laport, G. G.; Meyer, E. H.; Negrin, R. S.; Rezvani, A. R.; Wen-Kai Weng ; Sheehan, K.; Faham, M.; Okada, A.; Moore, A. H.; Phillips, D. L.; Wapnir, I. L.; Brody, J. D.; Levy, R. | Journal of Experimental Medicine | |||
| 16 | 2013 | Cancer Vaccines and T Cell Therapy | Rezvani, K.; Brody, J. D.; Kohrt, H. E.; Logan, A. C.; Advani, R.; Czerwinski, D. K.; Wen-Kai Weng ; Negrin, R. S.; Carlton, V.; Faham, M.; Levy, R.; Barrett, J. | Biology of Blood and Marrow Transplantation | |||
| 17 | 2013 | Cancer Vaccines and T Cell Therapy (vol 19, pg S97, 2013) | Rezvani, K.; Brody, J. D.; Kohrt, H. E.; Logan, A. C.; Advani, R.; Czerwinski, D. K.; Wen-Kai Weng ; Negrin, R. S.; Carlton, V.; Faham, M.; Levy, R.; Barrett, J. | Biology of Blood and Marrow Transplantation | |||
| 18 | 2019 | Characteristics of wave attenuation due to roughness of stepped obstacles | Ruey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li | Ships and Offshore Structures | 7 | ||
| 19 | 2004 | Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype | Wen-Kai Weng ; Czerwinski, D.; Timmerman, J.; Hsu, F. J.; Levy, R. | Journal of Clinical Oncology | |||
| 20 | 2017 | Consolidative CD8(+) Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation | Spinner, M. A.; Muffly, L. S.; Arai, S.; Johnston, L.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Strober, S.; Lowsky, R. | Blood | |||
| 21 | 2019 | Correlation of circulating EBV-targeted cytotoxic T lymphocyte precursors (EBV-CTLp) and clinical response following tabelecleucel (tab-cel) infusion in patients with EBV-driven disease | Aftab, B. T.; Munson, D.; Rasor, K.; Foubert, P.; Tsai, D. E.; Wen-Kai Weng ; Ghobadi, A.; Van Besien, K.; Sun, Y.; Hiremath, M.; Navarro, W. H.; Prockop, S. | Journal of Clinical Oncology | |||
| 22 | 2013 | Developing serpent-type wave generators to create solitary wave simulations with BEM | Wen-Kai Weng ; Ruey-Syan Shih ; Chung-Ren Chou | China Ocean Engineering | 0 | ||
| 23 | 1997 | Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells | Wen-Kai Weng ; Shah, N.; O'Brien, D.; Van Ness, B.; LeBien, T. W. | Journal of Immunology | |||
| 24 | 2015 | Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms | Narayan, R.; Benjamin, J.; Laport, G.; Tian, L.; Tate, K.; Elder, L.; Galvez, L.; Armstrong, R.; Sheehan, K.; Lowsky, R.; Arai, S.; Johnston, L.; Miklos, D.; Muffly, L. S.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Strober, S.; Negrin, R.; Meyer, E. | Blood | |||
| 25 | 2009 | A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis | Chen, G. L.; Arai, S.; Flowers, M. E. D.; Otani, J.; Cheng, E. C.; McMillan, A.; Wen-Kai Weng ; Shizuru, J.; Johnston, L.; Miklos, D. | Blood | |||
| 26 | 2016 | Dynamic Behaviors of a Moored Floating Structure with Flexible Skirts | Wen-Kai Weng ; Duc-Tru Tran; Ruey-Syan Shih | Journal of Energy and Power Engineering | 0 | ||
| 27 | 2013 | Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility | Benjamin, J.; Laport, G. G.; Tate, K.; Galvez, L.; Armstrong, R.; Sheehan, K.; Arai, S.; Lowsky, R.; Johnston, L.; Miklos, D. B.; Shizuru, J.; Wen-Kai Weng ; Negrin, R. | Blood | |||
| 28 | 2012 | Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab, cetuximab, and rituximab | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M.; Lund, P.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Sunwoo, J.; Tedder, T.; Chen, L. P.; Levy, R. | Journal of Clinical Oncology | |||
| 29 | 2017 | Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation | Kuklinski, L. F.; Li, S. F.; Karagas, M. R.; Wen-Kai Weng ; Kwong, B. Y. | Journal of the American Academy of Dermatology | |||
| 30 | 2018 | Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma | Spiegel, J. Y.; Sahaf, B.; Hossain, N.; Frank, M. J.; Claire, G.; Abramian, M.; Latchford, T.; Villa, B.; Cancilla, J.; Oak, J.; Natkunam, Y.; Long, S. R.; Arai, S.; Johnston, L. J.; Lowsky, R.; Meyer, E. H.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Kong, K. A.; Mackall, C. L.; Miklos, D. B. | Blood | |||
| 31 | 2005 | Enhancing the performance of organic light-emitting devices by selective thermal treatment | Sun, M. C.; Jou, J. H.; Wen-Kai Weng ; Huang, Y. S. | Thin Solid Films | |||
| 32 | 2019 | Enhancing Wave Energy Harvesting with a Submerged Crescent-Shaped Plate | Chi-Yu Li ; Wen-Kai Weng ; Ruey-Syan Shih ; Chia-Kai Yang; Jheng-Syuan Lo | Journal of Coastal Research | 0 | ||
| 33 | 2019 | Enhancing Wave Energy Harvesting with a Submerged Crescent-Shaped Plate | Li, Chi-Yu ; Weng, Wen-Kai ; Shih, Ruey-Syan ; Yang, Chia-Kai; Lo, Jheng-Syuan | JOURNAL OF COASTAL RESEARCH | 0 | ||
| 34 | 2014 | European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation | Medeiros, B. C.; Tian, L.; Robenson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Blood Cancer Journal | |||
| 35 | 2016 | Experimental determination of the performance characteristics of an undulating submerged obstacle | Shih, Ruey-Syan ; Weng, Wen-Kai | SHIPS OFFSHORE STRUC | 7 | ||
| 36 | 2011 | Experimental investigation on the effect of tensile pre-strain on ratcheting behavior of 430 Stainless Steel under fully-reversed loading condition | Chiou, Y. C.; Wen-Kai Weng ; Yi-Ming Jen | Engineering Failure Analysis | |||
| 37 | 2018 | Experimental Study on the Generation and Attenuation of Landslide Tsunamis | Shih, Ruey-Syan ; Weng, Wen-Kai ; Li, Chi-Yu | J COASTAL RES | 5 | ||
| 38 | 2001 | Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma | Wen-Kai Weng ; Levy, R. | Blood | |||
| 39 | 2004 | Fc-gamma R IIIa polymorphism and anti-idiotype humoral immune response predict clinical outcome in follicular lymphoma patients receiving idiotypic vaccination | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Journal of Clinical Oncology | |||
| 40 | 2004 | A fully human anti-CD40 antagonistic antibody, CHIR-12.12, inhibit the proliferation of human B cell non-Hodgkin's lymphoma | Wen-Kai Weng ; Tong, X. | Blood | |||
| 41 | 2017 | Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoides | Cedeno-Laurent, F.; Wysocka, M.; Obstfeld, A. E.; Novoa, R. A.; Vittorio, C. C.; Kim, E. J.; Wen-Kai Weng ; Rook, A. H. | Journal of Cutaneous Pathology | |||
| 42 | 2005 | Genetic polymorphism of the inhibitory IgG Fc receptor Fc gamma RIIb is not associated with clinical outcome of rituximab treated follicular lymphoma patients | Wen-Kai Weng ; Levy, R. | Blood | |||
| 43 | 2009 | Genetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab | Wen-Kai Weng ; Levy, R. | Leukemia & Lymphoma | |||
| 44 | 2015 | Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2 | Ungewickell, A.; Bhaduri, A.; Rios, E.; Reuter, J.; Lee, C. S.; Mah, A.; Zehnder, A.; Ohgami, R.; Kulkarni, S.; Armstrong, R.; Wen-Kai Weng ; Gratzinger, D.; Tavallaee, M.; Rook, A.; Snyder, M.; Kim, Y.; Khavari, P. A. | Nature Genetics | |||
| 45 | 2012 | Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | |||
| 46 | 2011 | Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Blood | |||
| 47 | 2018 | Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD) | Gupta, R.; Albabtain, A.; Arai, S.; Kwong, B.; Wen-Kai Weng | Blood | |||
| 48 | 2017 | Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma | Choi, T.; Kodali, M. K.; Wen-Kai Weng | Biology of Blood and Marrow Transplantation | |||
| 49 | 2003 | Hepatitis C virus (HCV) and lymphomagenesis | Wen-Kai Weng ; Levy, S. | Leukemia & Lymphoma | |||
| 50 | 2002 | High-efficiency white organic light-emitting devices with dual doped structure | Huang, Y. S.; Jou, J. H.; Wen-Kai Weng ; Liu, J. M. | Applied Physics Letters | |||
| 51 | 2012 | The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients | Kelly-Sell, M. J.; Kim, Y. H.; Straus, S.; Benoit, B.; Harrison, C.; Sutherland, K.; Armstrong, R.; Wen-Kai Weng ; Showe, L. C.; Wysocka, M.; Rook, A. H. | American Journal of Hematology | |||
| 52 | 2017 | HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity | Spinner, M. A.; Fernandez-Vina, M.; Creary, L. E.; Quinn, O.; Elder, L.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Shizuru, J. A.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R. | Blood Advances | |||
| 53 | 2001 | Human anti-CD40 antagonistic antibodies, inhibit the proliferation of human B cell non-Hodgkin's lymphoma | Wen-Kai Weng ; Wang, C. Y.; Chu, K. T.; Levy, R. | Blood | |||
| 54 | 2005 | Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Blood | |||
| 55 | 2007 | Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphorna patients regardless of their response to induction chemotherapy | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Blood | |||
| 56 | 2010 | Immunoglobulin G Fc Receptor Fc gamma RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma | Wen-Kai Weng ; Negrin, R. S.; Lavori, P.; Horning, S. J. | Journal of Clinical Oncology | |||
| 57 | 2004 | Immunoglobulin G Fc receptor polymorphisms and clinical course in follicular lymphoma patients | Wen-Kai Weng ; Rosenberg, A.; Levy, R. | Blood | |||
| 58 | 2009 | Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma | Wen-Kai Weng ; Levy, R. | Leukemia & Lymphoma | |||
| 59 | 2011 | Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results | Brody, J. D.; Czerwinski, D. K.; Carlton, V.; Moorhead, M.; Zheng, J. B. A.; Klinger, M.; Faham, M.; Advani, R.; Kohrt, H. E.; Alizadeh, A. A.; Negrin, R. S.; Weng, WK ; Sheehan, K.; Levy, R. | Blood | 0 | ||
| 60 | 2018 | Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation | Muffly, L.; Sheehan, K.; Armstrong, R.; Jensen, K.; Tate, K.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood Advances | |||
| 61 | 2020 | Investigation of Ocean-Wave-Focusing Characteristics Induced by a Submerged Crescent-Shaped Plate for Long-Crested Waves | Li, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai | WATER-SUI | 2 | ||
| 62 | 2025/1/28 | Kinetic characteristics of a moored floating structure with a liquid column vibration absorber (LCVA) | Wang, Bo-Jun; Lin, Ta-Wei; Li, Chi-Yu ; Weng, Wen-Kai | SHIPS AND OFFSHORE STRUCTURES | |||
| 63 | 2006 | The long term clinical outcome of B cell lymphoma patients treated with anti-idiotype monoclonal antibody correlated with the isotype of the therapeutic antibody | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Blood | |||
| 64 | 2016 | Long-Term Outcomes of AML Patients Using Total Lymphoid Irradiation with Anti-Thymocyte Globulin | Nakasone, H.; Miklos, D. B.; Meyer, E.; Rezvani, A.; Muffly, L.; Wen-Kai Weng ; Arai, S.; Johnston, L.; Laport, G. G.; Shizuru, J. A.; Negrin, R.; Strober, S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | |||
| 65 | 2016 | Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma | Neppalli, A. K.; Shizuru, J.; Johnston, L. J.; Muffly, L. S.; Wen-Kai Weng ; Negrin, R.; Meyer, E.; Laport, G.; Lowsky, R.; Arai, S.; Miklos, D. B.; Rezvani, A. R. | Journal of Clinical Oncology | |||
| 66 | 2020 | Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study | Prockop, S. E.; Reshef, R.; Tsai, D. E.; Bunin, N.; Abu-Arja, R.; Mahadeo, K. M.; Wen-Kai Weng ; van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E. R.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W. H.; Nikiforow, S. | Biology of Blood and Marrow Transplantation | |||
| 67 | 2013 | Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Desmarais, C.; Hoppe, R.; Kim, Y. H. | Science Translational Medicine | |||
| 68 | 2005 | A non-internalizing anti-CD40 antibody, CHIR-12.12, blocks CD40L-induced cytokine production and mediates greater ADCC than rituximab in primary CLL cells | Tong, X.; Aukerman, S. L.; Lin, K.; Aziz, N.; Goldbeck, C.; Georgakis, G. V.; Younes, G.; Wen-Kai Weng ; O'Brien, S.; Wierda, W.; Jallal, B.; Luqman, M. | Blood | |||
| 69 | 2014 | Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Benjamin, J. E.; Negrin, R. S.; Reddy, S.; Million, L.; Hoppe, R. T.; Kim, Y. H. | Blood | |||
| 70 | 2012 | Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms | Benjamin, J.; Chhabra, S.; Kohrt, H. E.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Blood | |||
| 71 | 2020 | Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma | Wen-Kai Weng ; Arai, S.; Rezvani, A.; Johnston, L.; Lowsky, R.; Miklos, D.; Shizuru, J.; Muffly, L.; Meyer, E.; Negrin, R. S.; Wang, E.; Almazan, T.; Million, L.; Khodadoust, M.; Li, S. F.; Hoppe, R. T.; Kim, Y. H. | Blood Advances | |||
| 72 | 2018 | Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Elder, L. V.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood | |||
| 73 | 2019 | Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood Advances | |||
| 74 | 2013 | Numerical Modeling of Wave Field Around Multiple Submerged Breakwaters | Ruey-Syan Shih ; Wen-Kai Weng ; Chung Ren Chou | Marine Science | 0 | ||
| 75 | 2015 | Numerical study of the characteristics of wave-wave interactions in a multiphase wave field | Ruey-Syan Shih ; Wen-Kai Weng | Engineering Analysis with Boundary Elements | 1 | ||
| 76 | 2014 | Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience | Wudhikarn, K.; Lavori, P.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Hoppe, R. T.; Benjamin, J.; Meyer, E.; Negrin, R.; Wen-Kai Weng | Biology of Blood and Marrow Transplantation | |||
| 77 | 2013 | Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation | Kanate, A. S.; Efron, B.; Chhabra, S.; Kohrt, H.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Benjamin, J.; Johnston, L.; Arai, S.; Wen-Kai Weng ; Negrin, R.; Strober, S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | |||
| 78 | 2008 | Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity | Kohrt, H.; Turnbull, B.; Laport, G.; Miklos, D.; Shizuru, J.; Johnston, L.; Arai, S.; Wen-Kai Weng ; Benjamin, J.; Blume, K.; Negrin, R.; Lavori, P.; Strober, S.; Lowsky, R. | Blood | |||
| 79 | - | Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma | Lemieux, C.; Muffly, L. S.; Rezvani, A.; Lowsky, R.; Iberri, D. J.; Craig, J. K.; Frank, M. J.; Johnston, L. J.; Liedtke, M.; Negrin, R.; Wen-Kai Weng ; Meyer, E.; Shizuru, J.; Shiraz, P.; Arai, S.; Miklos, D. B.; Sidana, S. | Bone Marrow Transplantation | |||
| 80 | 2015 | The performance characteristics of inclined highly pervious pipe breakwaters | Ruey-Syan Shih ; Wen-Kai Weng ; Chung-Ren Chou | Ocean Engineering | 12 | ||
| 81 | 2016 | Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation | Muffly, L. S.; Sheehan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | |||
| 82 | 2015 | Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis | Chu, M. P.; Brody, J.; Kohrt, H. E.; Frank, M. J.; Khodadoust, M.; Reddy, S.; Advani, R. H.; Gupta, N. K.; Laport, G.; Maeda, L. S.; Meyer, E.; Miklos, D. B.; Negrin, R.; Rezvani, A. R.; Wen-Kai Weng ; Sheehan, K.; Faham, M.; Czerwinski, D. K.; Okada, A.; Levy, R. | Blood | |||
| 83 | 2018 | Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells | Meyer, E.; Laport, G. G.; Tantsura, I.; Tang, S. W.; Sahaf, B.; Rangarajan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Sheehan, K.; Arai, S.; Johnston, L.; Muffly, L.; Lowsky, R.; Rezvani, A.; Wen-Kai Weng ; Miklos, D.; Negrin, R. S. | Biology of Blood and Marrow Transplantation | |||
| 84 | 2008 | Phase I/II Trial of a Novel Gemcitabine and Vinorelbine-Containing Conditioning Regimen in Autologous Hemotopoietic Cell Transplantation for High-Risk Recurrent and Refractory Hodgkin Lymphoma | Arai, S.; Letsinger, R.; Johnston, L.; Laport, G.; Lowsky, R.; Miklos, D.; Shizuru, J.; Wen-Kai Weng ; Wong, R.; Lavori, P.; Blume, K.; Negrin, R.; Horning, S. | Blood | |||
| 85 | 2010 | Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma | Arai, S.; Letsinger, R.; Wong, R. M.; Johnston, L. J.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Horning, S. J. | Biology of Blood and Marrow Transplantation | |||
| 86 | 2015 | Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project | Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; Hoppe, R. T.; Nguyen-Lin, A.; Wen-Kai Weng ; Armstrong, R.; Pulitzer, M.; Advani, R. H.; Horwitz, S. M. | Journal of Clinical Oncology | |||
| 87 | 2015 | A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia | Strati, P.; Tong, W. G.; Vitale, C.; Wierda, W. G.; O'Brien, S.; Brown, J. R.; Wen-Kai Weng ; Kipps, T.; Keating, M. J.; Ferrajoli, A. | Leukemia & Lymphoma | |||
| 88 | 2005 | A polymorphism in the C1qA component of complement correlates with prolonged complete remission following rituximab therapy of follicular lymphoma | Racila, E.; Wen-Kai Weng ; Wooldridge, J. E.; Link, B. K.; Levy, R.; Weiner, G. J. | Blood | |||
| 89 | 2008 | A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma | Racila, E.; Link, B. K.; Wen-Kai Weng ; Witzig, T. E.; Ansell, S.; Maurer, M. J.; Huang, J.; Dahle, C.; Halwani, A.; Levy, R.; Weiner, G. J. | Clinical Cancer Research | |||
| 90 | 2018 | Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sezary Syndrome | Dai, J.; Almazan, T. H.; Hong, E. K.; Khodadoust, M. S.; Arai, S.; Wen-Kai Weng ; Kim, Y. H. | Jama Dermatology | |||
| 91 | 2007 | The prediction of the dynamic and structural motions of a floating-pier system in waves | Lee, H. H.; Chen, L. Y.; Wen-Kai Weng ; Shyue, S. W. | Ocean Engineering | |||
| 92 | 2012 | Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence | Arai, S.; Sahaf, B.; Narasimhan, B.; Chen, G. L.; Jones, C. D.; Lowsky, R.; Shizuru, J. A.; Johnston, L. J.; Laport, G. G.; Wen-Kai Weng ; Benjamin, J. E.; Schaenman, J.; Brown, J.; Ramirez, J.; Zehnder, J. L.; Negrin, R. S.; Miklos, D. B. | Blood | |||
| 93 | 2008 | Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results in Low Chronic Gvhd | Arai, S.; Sahaf, B.; Jones, C.; Zhender, J.; Lowsky, R.; Strober, S.; Shizuru, J.; Negrin, R.; Johnston, L.; Laport, G.; Schaenman, J.; Brown, J.; Wen-Kai Weng ; Letsinger, R.; Wong, R.; Lavori, P.; Miklos, D. | Blood | |||
| 94 | 2011 | A prospective trial of low-dose total skin electron beam therapy in mycosis fungoides and proposal of a new clinically meaningful endpoint | Bashey, S.; Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Wen-Kai Weng ; Sundram, U.; Kim, Y. H.; Hoppe, R. | Journal Der Deutschen Dermatologischen Gesellschaft | |||
| 95 | 2022 | Relative Energy Variation Characteristics Considering Interaction between Waves and Vegetation Structure | Shih, Ruey-Syan ; Li, Chi-Yu ; Weng, Wen-Kai ; Lin, Chih-Hung | WATER-SUI | 0 | ||
| 96 | 2012 | RETRACTED: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retracted article. See vol. 129, pg. 2595, 2019) | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Stockdale, F. E.; Mollick, J. A.; Chen, L. P.; Levy, R. | Journal of Clinical Investigation | |||
| 97 | 2014 | RETRACTED: Targeting CD137 enhances the efficacy of cetuximab (Retracted article. See vol. 129, pg. 2595, 2019) | Kohrt, H. E.; Colevas, A. D.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Lund, P.; Mueller, A.; Sagiv-Barfi, I.; Marabelle, A.; Lira, R.; Troutner, E.; Richards, L.; Rajapaska, A.; Hebb, J.; Chester, C.; Waller, E.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Czerwinski, D.; Fu, Y. X.; Sunwoo, J.; Levy, R. | Journal of Clinical Investigation | |||
| 98 | 2019 | RETRACTION: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retraction of Vol 122, Pg 1066, 2012) | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Stockdale, F. E.; Mollick, J. A.; Chen, L. P.; Levy, R. | Journal of Clinical Investigation | |||
| 99 | 2019 | RETRACTION: Targeting CD137 enhances the efficacy of cetuximab (Retraction of Vol 124, Pg 2668, 2014) | Kohrt, H. E.; Colevas, A. D.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Lund, P.; Mueller, A.; Sagiv-Barfi, I.; Marabelle, A.; Lira, R.; Troutner, E.; Richards, L.; Rajapaska, A.; Hebb, J.; Chester, C.; Waller, E.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Czerwinski, D.; Fu, Y. X.; Sunwoo, J.; Levy, R. | Journal of Clinical Investigation | |||
| 100 | 2016 | Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk | Kuklinski, L. F.; Li, S. F.; Karagas, M. R.; Kwong, B. Y.; Wen-Kai Weng | Blood | |||
| 101 | 2005 | Rituximab variants with re-engineered Fc with higher affinity to activating Fc gamma R eliminate the functional difference between Fc gamma R genotypes | Wen-Kai Weng ; Stavenhagen, J.; Koenig, S.; Levy, R. | Blood | |||
| 102 | 2001 | Rituximab-induced Annexin-V staining of tumor cells does not predict clinical outcome following Rituximab treatment in follicular non-Hodgkin's lymphoma | Wen-Kai Weng ; Levy, R. | Blood | |||
| 103 | 2002 | Rituximab-induced antibody-dependent cellular cytotoxicity (ADCC) in follicular non-Hodgkin's lymphoma | Wen-Kai Weng ; Levy, R. | Blood | |||
| 104 | 1995 | SIGNALING THROUGH CD19 ACTIVATES AP1 TRANSCRIPTION FACTORS IN HUMAN B-LINEAGE CELLS | Wen-Kai Weng ; Obrien, D.; Vanness, B.; Lebien, T. W. | Faseb Journal | |||
| 105 | 2016 | A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT) | Kim, Y. H.; Hoppe, R. T.; Rook, A. H.; Maity, A.; Geskin, L. J.; Horowitz, D. P.; Finnegan, G.; Khodadoust, M.; Wen-Kai Weng ; Lares, A.; Hong, E. K. J.; Buchanan, M.; Ma, V.; Kha, H.; Lawrence, C. E.; Vainstein, V.; Basile, L. A. | Blood | |||
| 106 | 2001 | Studies on modifications of ITO surfaces in OLED devices by Taguchi methods | Liu, J. M.; Lu, P. Y.; Wen-Kai Weng | Materials Science and Engineering B-Solid State Materials for Advanced Technology | |||
| 107 | 2020 | Study of a deep draft vessel to enhance onsite installation capability of a jack up type unit operating in the wind farm zone offshore of the Taichung Harbor Taiwan | Y.Z. Kehr; G.A. Chang; G.J. Huang; Wen-Kai Weng | OCEAN ENG | 1 | ||
| 108 | 2016 | A Study of Long Wave Attenuation over Composite Undulating Breakwaters | Shih, Ruey-Syan ; Weng, Wen-Kai | J COASTAL RES | 5 | ||
| 109 | 2012 | Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma | Chen, A. I.; Negrin, R. S.; McMillan, A.; Shizuru, J. A.; Johnston, L. J.; Lowsky, R.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Laport, G. G.; Stockerl-Goldstein, K. | Bone Marrow Transplantation | |||
| 110 | 2013 | Targeting CD137 to enhance the antitumor efficacy of cetuximab by stimulation of innate and adaptive immunity | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M.; Lund, P.; Lira, R. R.; Troutner, E.; Richards, L.; Rajapaksa, A.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Colevas, C. A. D.; Sunwoo, J.; Levy, R. | Journal of Clinical Oncology | |||
| 111 | 2009 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Kohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | |||
| 112 | 2013 | TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN | Benjamin, J.; Chhabra, S.; Kohrt, H.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R.; Lowsky, R. | Biology of Blood and Marrow Transplantation | |||
| 113 | 2014 | Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms | Benjamin, J.; Chhabra, S.; Kohrt, H. E.; Lavori, P.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | |||
| 114 | 2012 | Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts | Lee, C. S.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D. E.; Armstrong, R.; Wen-Kai Weng ; Aros, C. J.; Mah, A.; Chen, R. O.; Lin, M. H.; Sundram, U.; Chang, H. Y.; Kretz, M.; Kim, Y. H.; Khavari, P. A. | Blood | |||
| 115 | 2019 | Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients | Meyer, E. H.; Laport, G.; Xie, B. J.; MacDonald, K.; Heydari, K.; Sahaf, B.; Tang, S. W.; Baker, J.; Armstrong, R.; Tate, K.; Tadisco, C.; Arai, S.; Johnston, L.; Lowsky, R.; Muffly, L.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Sheehan, K.; Miklos, D.; Negrin, R. S. | Jci Insight | |||
| 116 | 2009 | Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma | Timmerman, J. M.; Vose, J. M.; Czerwinski, D. K.; Wen-Kai Weng ; Ingolia, D.; Mayo, M.; Denney, D. W.; Levy, R. | Leukemia & Lymphoma | |||
| 117 | 2003 | Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma | Wen-Kai Weng ; Levy, R. | Journal of Clinical Oncology | |||
| 118 | 2005 | Use of dendritic cells and GM-CSF adjuvant are associated with anti-idiotype cellular immune response following idiotype vaccination in follicular lymphoma patients | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Blood | |||
| 119 | 2014 | Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Hoppe, R. T.; Meyer, E. H.; Kim, Y. H. | Blood | |||
| 120 | 2014 | The utility of HTS TCR analyses in the management of patients with T-cell malignancies | Kirsch, I. L.; Sherwood, A.; Williamson, D.; Wen-Kai Weng ; Clark, R.; Kupper, T. S.; Wu, D.; Robins, H. | Journal of Clinical Oncology | |||
| 121 | 2017 | Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation | Veeraputhiran, M.; Yang, L. Y.; Sundaram, V.; Arai, S.; Lowsky, R.; Miklos, D.; Meyer, E.; Muffly, L.; Negrin, R.; Rezvani, A.; Shizuru, J.; Wen-Kai Weng ; Johnston, L. | Biology of Blood and Marrow Transplantation | |||
| 122 | 2020 | Visualization Investigation of Energy Dissipation Induced by Eddy Currents for a Solitary-Like Wave Passing over Submerged Breakwater Sets | Li, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai | J MAR SCI ENG | 3 | ||
| 123 | 2019 | Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs | Obeid, J. P.; Gutkin, P. M.; Lewis, J.; Skinner, L.; Wang, E. B.; Khodadoust, M. S.; Kim, Y. H.; Wen-Kai Weng ; Hoppe, R. T.; Hiniker, S. M. | Practical Radiation Oncology | |||
| 124 | 2006 | Wave setup and setdown generated by obliquely incident waves | Tai-Wen Hsu ; Hsu, J. R. C.; Wang, S. K.; Ou, S. H.; Wen-Kai Weng | Coastal Engineering | |||
| 125 | 2020 | Wave-Structure-Current interactions over smooth and rough breakwaters | Ruey-Syan Shih ; Chi-Yu Li ; Wen-Kai Weng | Ships and Offshore Structures | 0 |
